As a key protein participated in iron metabolism and antioxidant defense, the level of Cp during the acute phase is regulated in response to inflammation, infection, copper and iron metabolism disorders, and vascular injury (Daimon et al., 1998; Golizeh et al., 2017). This evidence concerns the gene CP and metabolic disease.